|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 31/5365 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| A61P 31/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3856774 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19732147.4 |
| Date of filing the European patent application | 2019-04-24 | |
| (97) | Date of publication of the European application | 2021-08-04 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-02 |
| (46) | Date of publication of the claims translation | 2023-03-10 |
| (86) | Number | PCT/US2019/028953 |
| Date | 2019-04-24 |
| (87) | Number | WO 2020/081119 |
| Date | 2020-04-23 |
| (30) | Number | Date | Country code |
| 201862745914 P | 2018-10-15 | US |
| (72) |
SMITT, Melanie , US
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Liekamojo krūties vėžio gydymo trastuzumabo emtanzinu būdai |
| METHODS OF TREATING RESIDUAL BREAST CANCER WITH TRASTUZUMAB EMTANSINE |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 8 | 185.00 EUR |
| 2027-04-24 |